Influence of atorvastatin therapy on galectin-3, VE-cadherin, and cardiovascular risk in patients with chronic lymphocytic leukemia

Abstract

Aims: We aimed to evaluate the impact of atorvastatin on galectin-3 and VE-cadherin, and cardiovascular risk in patients with chronic lymphocytic leukemia in remission.

Description

Keywords

тези доповідей

Citation

Samura B. Influence of atorvastatin therapy on galectin-3, VE-cadherin, and cardiovascular risk in patients with chronic lymphocytic leukemia / B. Samura, Y. Kolestik, V. Syvolap // HemaSphere : Abstr. Book of 24th Congr. of the European Hematology Association, June 13-16, 2019, in Amsterdam, Netherlands. - 2019. - Vol. 3, S1. - P . 148. - 10.1097/01.HS9.0000559776.66688.50.

Endorsement

Review

Supplemented By

Referenced By